Groupe pharmaceutique · États-Unis
Eli Lilly
Un groupe de 36 sociétés, avec 907 médicaments dans 10 pays.
Structure du groupe
36 sociétés dans 14 pays
Chargement de votre page…
Chargement de votre page…
Groupe pharmaceutique · États-Unis
Un groupe de 36 sociétés, avec 907 médicaments dans 10 pays.
36 sociétés dans 14 pays
Un compte gratuit pour les apps Prognia : Ward pour réviser, Osler pour des réponses cliniques avec leurs sources, et le réseau pour retrouver vos collègues.
Les groupes sont constitués par Prognia à partir des noms publiés par les autorités et des liens entre sociétés ; ils ne reflètent pas une structure juridique officielle.
Tous les médicaments de toutes les sociétés du groupe, les actuels d’abord.
1–25 sur 907
| Médicament | Substance active | Pays | Statut | Autorisation |
|---|---|---|---|---|
| ABASAGLARSoluzione iniettabile | Insulin glargine | Italie | Autorisé | |
| ABASAGLAR 100 E/ml, oplossing voor injectie in een patroonOplossing voor injectie | Insulin glargine | Pays-Bas | Autorisé | 2014 |
| ABASAGLAR 100 E/ml, oplossing voor injectie in een voorgevulde penOplossing voor injectie | Insulin glargine | Pays-Bas | Autorisé | 2014 |
| ABASAGLAR 100 UNIDADES/ML KWIKPEN SOLUCION INYECTABLE EN PLUMA PRECARGADA100 u · Solución inyectable en pluma precargada | Insulin glargine | Espagne | Commercialisé | 2016 |
| Abasaglar (previously Abasria) | Insulin glargine | UE (EMA) | Autorisé | 2014 |
| ADCIRCACompressa rivestita con film | Tadalafil | Italie | Autorisé | |
| ADCIRCA20mg · Tablet | Tadalafil | États-Unis | Commercialisé | 2009 |
| Adcirca 2 mg/ml orale suspensieSuspensie voor oraal gebruik | Tadalafil | Pays-Bas | Autorisé | 2023 |
| ADCIRCA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA20 mg · Comprimido recubierto con película | Tadalafil | Espagne | Commercialisé | 2010 |
| ADCIRCA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA20 mg · Comprimido recubierto con película | Tadalafil | Espagne | Autorisé | 2010 |
| Adcirca 20 mg, filmomhulde tablettenFilmomhulde tablet | Tadalafil | Pays-Bas | Autorisé | 2008 |
| Adcirca (previously Tadalafil Lilly) | Tadalafil | UE (EMA) | Autorisé | 2008 |
| AEROLONE0.25% · Solution | Isoprenaline | États-Unis | Non commercialisé | |
| ALIMTA500mg · Injectable | Pemetrexed | États-Unis | Commercialisé | 2004 |
| ALIMTA | Pemetrexed | Brésil | Autorisé | 2004 |
| Alimta | Pemetrexed | UE (EMA) | Autorisé | 2004 |
| ALIMTA100mg base/vial | 500mg base/vial · Powder | Pemetrexed | États-Unis | Commercialisé | 2004 |
| ALIMTAPolvere per concentrato per soluzione per infusione | Pemetrexed | Italie | Autorisé | |
| Alimta 100 mg poeder voor concentraat voor oplossing voor intraveneuze infusiePoeder voor concentraat voor oplossing voor infusie | Pemetrexed | Pays-Bas | Autorisé | 2007 |
| ALIMTA 100 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION100 mg · Polvo para concentrado para solución para perfusión | Pemetrexed | Espagne | Commercialisé | 2008 |
| Alimta 500 mg, poeder voor concentraat voor oplossing voor intraveneuze infusiePoeder voor oplossing voor injectie | Pemetrexed | Pays-Bas | Autorisé | 2004 |
| ALIMTA 500 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION500 mg · Polvo para concentrado para solución para perfusión | Pemetrexed | Espagne | Commercialisé | 2004 |
| ALIMTA 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION500 mg · Polvo para concentrado para solución para perfusión | Pemetrexed | Espagne | Autorisé | 2019 |
| ALPHALIN50,000 units base · Capsule | Vitamin a palmitate | États-Unis | Non commercialisé | 1973 |
| AMYVIDSoluzione iniettabile | Florbetapir (18f) | Italie | Autorisé |
Où ses médicaments sont enregistrés ou fabriqués, et combien sont actuels.
| Pays | Médicaments | Actuels | Anciens | Sociétés |
|---|---|---|---|---|
| Canada | 194 | 85 | 109 | SociétésTous les médicaments |
| États-Unis | 160 | 157 | 3 | SociétésTous les médicaments |
| Espagne | 159 | 147 | 12 | SociétésTous les médicaments |
| Pays-Bas | 114 | 114 | 0 | SociétésTous les médicaments |
| Arabie saoudite | 91 | 91 | 0 | SociétésTous les médicaments |
| Brésil | 75 | 20 | 55 | SociétésTous les médicaments |
| Roumanie | 42 | 0 | 42 | SociétésTous les médicaments |
| Union européenne (EMA) | 40 | 28 | 12 | SociétésTous les médicaments |
| Italie | 29 | 29 | 0 | SociétésTous les médicaments |
| Croatie | 3 | 3 | 0 | SociétésTous les médicaments |
Également dans les registres : France, Royaume-Uni, Serbie, Singapour
Les groupes ATC auxquels appartiennent la plupart de ses médicaments, les plus importants d’abord.
Les substances actives présentes dans la plupart de ses médicaments.
Comment les registres l’écrivent, normalisé : sans forme juridique, accents ni majuscules.
Compilé par Prognia à partir des registres publics de médicaments et d’entreprises ci-dessous. Aucun logo n’est utilisé.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence : EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence : AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence : Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence : Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence : Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence : Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence : Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence : Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence : Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence : AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence : AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence : BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licence : Licence Ouverte / Open Licence
Companies House, Find and update company information; exact company number and page URL, accessed 8 October 2026. Structured factual extraction by Prognia. Crown-created website material under OGL 3.0: https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Licence : Companies House statutory public-register use; OGL 3.0 for Crown-created website material
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence : Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence : Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence : CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence : Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence : Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence : Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence : Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence : Creative Commons Attribution 4.0 International (CC BY 4.0)
Oficiul Național al Registrului Comerțului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licence : Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence : Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence : Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence : Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence : FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Signaler une erreur ou demander un retraitLes corrections de la société elle-même sont les bienvenues.
Eli Lilly : veillez à l’exactitude de vos médicaments sur Prognia, voyez comment les professionnels les utilisent et répondez à leurs questions. Un appel de 20 minutes, en anglais.
Réserver un appelDes groupes pharmaceutiques connus, chacun avec toutes ses sociétés.
Classés selon leur nombre de médicaments.